Advertisement
Review

A Research Agenda to Underpin Malaria Eradication

  • Pedro L. Alonso mail,

    palonso@clinic.ub.es

    Affiliations: Barcelona Centre for International Health Research (Hospital Clínic, Universitat de Barcelona), Barcelona, Spain, Centro de Investigaçao em Saude da Manhiça, Maputo, Mozambique

    X
  • Graham Brown,

    Affiliation: Nossal Institute for Global Health, University of Melbourne, Melbourne, Australia

    X
  • Myriam Arevalo-Herrera,

    Affiliations: Immunology Institute-Universidad del Valle, Cali, Colombia, Centro de Investigación Caucaseco, Cali, Colombia

    X
  • Fred Binka,

    Affiliation: School of Public Health, University of Ghana, Accra, Ghana

    X
  • Chetan Chitnis,

    Affiliation: International Center for Genetic Engineering and Biotechnology, Delhi, India

    X
  • Frank Collins,

    Affiliation: University of Notre Dame, Notre Dame, Indiana, United States of America

    X
  • Ogobara K. Doumbo,

    Affiliation: University of Bamako, Bamako, Mali

    X
  • Brian Greenwood,

    Affiliation: London School of Hygiene & Tropical Medicine, London, United Kingdom

    X
  • B. Fenton Hall,

    Affiliation: National Institute of Allergy and Infectious Diseases (NIAID), Baltimore, Maryland, United States of America

    X
  • Myron M. Levine,

    Affiliation: Center for Vaccine Development, University of Maryland, Baltimore, Maryland, United States of America

    X
  • Kamini Mendis,

    Affiliation: Global Malaria Program, World Health Organization, Geneva, Switzerland

    X
  • Robert D. Newman,

    Affiliation: Global Malaria Program, World Health Organization, Geneva, Switzerland

    X
  • Christopher V. Plowe,

    Affiliation: Howard Hughes Medical Institute/University of Maryland School of Medicine, Baltimore, Maryland, United States of America

    X
  • Mario Henry Rodríguez,

    Affiliation: Instituto Nacional de Salud Pública, Cuernavaca, Mexico

    X
  • Robert Sinden,

    Affiliation: Imperial College, London, United Kingdom

    X
  • Laurence Slutsker,

    Affiliation: US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

    X
  • Marcel Tanner

    Affiliation: Swiss Tropical and Public Health Institute and University of Basel, Basel, Switzerland

    X
  • Published: January 25, 2011
  • DOI: 10.1371/journal.pmed.1000406
  • Published in PLOS Medicine

About the Authors

Pedro L. Alonso
Barcelona Centre for International Health Research (Hospital Clínic, Universitat de Barcelona), Barcelona, Spain
Pedro L. Alonso
Centro de Investigaçao em Saude da Manhiça, Maputo, Mozambique
Graham Brown
Nossal Institute for Global Health, University of Melbourne, Melbourne, Australia
Myriam Arevalo-Herrera
Immunology Institute-Universidad del Valle, Cali, Colombia
Myriam Arevalo-Herrera
Centro de Investigación Caucaseco, Cali, Colombia
Fred Binka
School of Public Health, University of Ghana, Accra, Ghana
Chetan Chitnis
International Center for Genetic Engineering and Biotechnology, Delhi, India
Frank Collins
University of Notre Dame, Notre Dame, Indiana, United States of America
Ogobara K. Doumbo
University of Bamako, Bamako, Mali
Brian Greenwood
London School of Hygiene & Tropical Medicine, London, United Kingdom
B. Fenton Hall
National Institute of Allergy and Infectious Diseases (NIAID), Baltimore, Maryland, United States of America
Myron M. Levine
Center for Vaccine Development, University of Maryland, Baltimore, Maryland, United States of America
Kamini Mendis, Robert D. Newman
Global Malaria Program, World Health Organization, Geneva, Switzerland
Christopher V. Plowe
Howard Hughes Medical Institute/University of Maryland School of Medicine, Baltimore, Maryland, United States of America
Mario Henry Rodríguez
Instituto Nacional de Salud Pública, Cuernavaca, Mexico
Robert Sinden
Imperial College, London, United Kingdom
Laurence Slutsker
US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
Marcel Tanner
Swiss Tropical and Public Health Institute and University of Basel, Basel, Switzerland

Corresponding Author

Email: palonso@clinic.ub.es

Competing Interests

GB declares that he is Chair of MALVAC, Chair USAID Malaria Vaccine Development Program Scientific Consultants Group, a member of the Board of Roll Back Malaria, and a member of the APMEN Advisory Board.

Author Contributions

ICMJE criteria for authorship read and met: PLA GVB MA FB CEC FHC OKD BG BFH MML KM RDN CVP MHR RES LS MT. Agree with the manuscript's results and conclusions: PLA GVB MA FB CEC FHC OKD BG BFH MML KM RDN CVP MHR RES LS MT. Wrote the first draft of the paper: PLA GVB MT. Contributed to the writing of the paper: PLA GVB MA FB CEC FHC OKD BG BFH MML KM RN CVP MHR RES LS MT. Contributed to the development of the research agenda: PLA GVB MA FB CEC FHC OKD BG BFH MML KM RDN CVP MHR RES LS MT. Members of the malERA steering committee which coordinated the malERA review process and guided the direction of the other papers in the series: PLA MA FB CEC FHC OKD BG BFH KM CVP MHR RES LS MT. Members of the malERA International Advisory Committee: GB MML. Contributed conceptually to the whole process leading to this paper: PLA GVB MA FB CEC FHC OKD BG BFH MML KM RDN CVP MHR RES LS MT.